Analysis of Fas and Fas ligand expression and function in lung cancer cell lines

By Kawasaki M.   Kuwano K.   Nakanishi Y.   Hagimoto N.   Takayama K.   Pei X.-H.   Maeyama T.   Yoshimi M.   Hara N.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 656-663

Elsevier

Access to resources Recommend Favorite

Isolinderalactone inhibits proliferation of A549 human nonsmall cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway

By          

Molecular Medicine Reports, Vol. 9, Iss. 5, 2014-01 ,pp. : 1653-1659

Spandidos Publications

Access to resources Recommend Favorite

Cell cycle-related expression and ligand binding of peripheral benzodiazepine receptor in human breast cancer cell lines

By Sanger N.   Strohmeier R.   Kaufmann M.   Kuhl H.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2157-2163

Elsevier

Access to resources Recommend Favorite

Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines

By Rajashekhar G.   Loganath A.   Roy A.C.   Mongelli J.M.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 101-111

Elsevier

Access to resources Recommend Favorite

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas

By Gutierrez L.S.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite